CN Bio Innovations, an expert in developing human biomimetic platforms to test and develop therapeutics for liver diseases and infection, is pleased to announce that it has embarked on a research collaboration with RNAi-based therapeutics company, Benitec Biopharma Limited (ASX:BLT).

Read full press release

← Back To All News


We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

Update!

CN Bio has capped a busy and successful year off by moving offices to the Cambridge Science Park where we have moved to larger purpose-fitted facilities.

Please update your records with our new contact information.

New Street Address & Mailing Address
332 Cambridge Science Park
Milton Road
Cambridge
CB4 0WN

Tel: 01223 737941

Wishing you, your family and colleagues a very Happy Holiday season from all of the team at CN Bio.